O'Brien P Q, Fischer A B, Yamamoto T. "一种的合成方法" [P]. US Patent, US 9371687 B2, 2016-01-21.
发明人刘建华,高志强,唐晓军. "Method for the Synthesis of Ethyl 5-oxo-5-(phenanthren-9-yl)pentanoate" [P]. 中国发明专利, 专利号 CN 117166135 A, 授权公告日 2022-09-10.
发明人王建平,陈志强,胡光. "A Process for Preparing High-Purity Ethyl 5-oxo-5-(phenanthren-9-yl)pentanoate" [P]. 中国发明专利, 专利号 CN 115741807 B, 授权公告日 2016-09-16.
参考文献 Literature
Zhou X P, Huang L, Wu G. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Molecules, 2015, 1886, 4292-4313.
Smith J A, Johnson M B. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Biomed. Chromatogr., 2011, 1316, (6), 238-253.
Wang L, Li J, Zhang H. "Identification and Structural Characterization of a Novel Degradation Product of Ethyl 5-oxo-5-(phenanthren-9-yl)pentanoate Using HRMS and NMR". Anal. Chem., 2025, 2174, (12), 524-530.
Jensen P, Larsen A M, Olsen K. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". J. Sep. Sci., 2013, 434, 2581-2593.